Diabetes Mellitus, Type 2

SEP 8, 2026 · PHASE 2 TRIAL

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

ClinicalTrials.gov

This is a Phase 2 trial registration with no reported results; the study is actively recruiting and outcome data are not yet available.

AUG 17, 2026 · OBSERVATIONAL STUDY

Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus

ClinicalTrials.gov

This is a completed observational study registration with no results posted; the study design and enrollment are documented but outcomes remain unreported in this registry record.

AUG 10, 2026 · OBSERVATIONAL STUDY

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors

ClinicalTrials.gov

This is a completed observational registry record with no results posted; it describes a planned study design and hypothesis only, without outcome data or effect estimates.

AUG 7, 2026 · INTERVENTIONAL STUDY

Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

ClinicalTrials.gov

This is a registered but actively recruiting trial with no reported results; the study design is sound but outcomes remain unposted in the registry.

AUG 5, 2026 · JOURNAL ARTICLE

Apoptosis protein markers in comorbid type 2 diabetes mellitus and depression; relationships with cognitive performance, incident dementia, and white matter hyperintensities.

Journal of Affective Disorders

A large retrospective cohort study identifying novel proteomic markers associated with dementia risk in comorbid T2DM and MDD, with clear statistical associations but requiring prospective validation and mechanistic confirmation.

JUL 25, 2026 · JOURNAL ARTICLE

Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial.

American Heart Journal

This is a vanguard phase report describing trial design, recruitment experiences, and baseline characteristics of 200 randomized participants in an ongoing RCT; no efficacy or safety outcomes are reported.

JUL 10, 2026 · JOURNAL ARTICLE

Crosstalk between sleep disorders and adipokine secretory profiles: novel mechanisms for metabolic disease risk.

Annals of Medicine

A mechanistic review synthesizing bidirectional relationships between sleep disorders and metabolic disease via adipokine dysregulation, offering a framework for clinical integration but presenting no new primary data or controlled evidence.

APR 14, 2026 · JOURNAL ARTICLE

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.

Annals of Medicine

Observational comparative effectiveness study with IPTW adjustment showing aspirin associated with lower mortality than alternatives in diabetic PAD patients with foot disease, but findings are from registry data without randomization and require prospective verification.